225 related articles for article (PubMed ID: 29301568)
1. Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.
Warford JR; Lamport AC; Clements DR; Malone A; Kennedy BE; Kim Y; Gujar SA; Hoskin DW; Easton AS
Acta Neuropathol Commun; 2018 Jan; 6(1):4. PubMed ID: 29301568
[TBL] [Abstract][Full Text] [Related]
2. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
[TBL] [Abstract][Full Text] [Related]
3. Experimental autoimmune encephalomyelitis accelerates remyelination after lysophosphatidylcholine-induced demyelination in the corpus callosum.
Lamport AC; Chedrawe M; Nichols M; Robertson GS
J Neuroimmunol; 2019 Sep; 334():576995. PubMed ID: 31228686
[TBL] [Abstract][Full Text] [Related]
4. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
Front Immunol; 2021; 12():792465. PubMed ID: 34975892
[TBL] [Abstract][Full Text] [Related]
5. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
Stephenson EL; Mishra MK; Moussienko D; Laflamme N; Rivest S; Ling CC; Yong VW
Brain; 2018 Apr; 141(4):1094-1110. PubMed ID: 29506186
[TBL] [Abstract][Full Text] [Related]
7. IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
Psachoulia K; Chamberlain KA; Heo D; Davis SE; Paskus JD; Nanescu SE; Dupree JL; Wynn TA; Huang JK
Brain; 2016 Dec; 139(Pt 12):3121-3136. PubMed ID: 27797811
[TBL] [Abstract][Full Text] [Related]
8. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
9. Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination.
Ghorbani S; Jelinek E; Jain R; Buehner B; Li C; Lozinski BM; Sarkar S; Kaushik DK; Dong Y; Wight TN; Karimi-Abdolrezaee S; Schenk GJ; Strijbis EM; Geurts J; Zhang P; Ling CC; Yong VW
Nat Commun; 2022 May; 13(1):2445. PubMed ID: 35508608
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms Involved in the Remyelinating Effect of Sildenafil.
Díaz-Lucena D; Gutierrez-Mecinas M; Moreno B; Martínez-Sánchez JL; Pifarré P; García A
J Neuroimmune Pharmacol; 2018 Mar; 13(1):6-23. PubMed ID: 28776122
[TBL] [Abstract][Full Text] [Related]
11. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
Lau LW; Keough MB; Haylock-Jacobs S; Cua R; Döring A; Sloka S; Stirling DP; Rivest S; Yong VW
Ann Neurol; 2012 Sep; 72(3):419-32. PubMed ID: 23034914
[TBL] [Abstract][Full Text] [Related]
12. Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis.
Navarrete C; García-Martin A; Garrido-Rodríguez M; Mestre L; Feliú A; Guaza C; Calzado MA; Muñoz E
Neurobiol Dis; 2020 Sep; 143():104994. PubMed ID: 32599064
[TBL] [Abstract][Full Text] [Related]
13. The effect of calcitriol and all-trans retinoic acid on T-bet, IFN-γ, GATA3 and IL-4 genes expression in experimental autoimmune encephalomyelitis.
Parastouei K; Solaymani-Mohammadi F; Shiri-Shahsavar MR; Chahardoli R; Nasl-Khameneh AM; Zarandi MB; Ghotloo S; Saboor-Yaraghi AA
APMIS; 2020 Nov; 128(11):583-592. PubMed ID: 32865844
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
15. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a hybrid between the synapsin ABC domains and the B subunit of E. coli heat-labile toxin reduces frequency of proinflammatory cells and cytokines in the central nervous system of rats with EAE.
Bibolini MJ; Scerbo MJ; Roth GA; Monferran CG
Neuroscience; 2014 Sep; 277():217-28. PubMed ID: 25020120
[TBL] [Abstract][Full Text] [Related]
17. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
18. Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination.
Pennati A; Nylen EA; Duncan ID; Galipeau J
J Neurosci; 2020 Jun; 40(26):5105-5115. PubMed ID: 32430295
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis.
Ara J; See J; Mamontov P; Hahn A; Bannerman P; Pleasure D; Grinspan JB
J Neurosci Res; 2008 Jan; 86(1):125-35. PubMed ID: 17722066
[TBL] [Abstract][Full Text] [Related]
20. Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders.
Mausner-Fainberg K; Benhamou M; Golan M; Kimelman NB; Danon U; Marom E; Karni A
Neurotherapeutics; 2021 Jul; 18(3):1798-1814. PubMed ID: 34159538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
